THE SPANNER TEMPORARY PROSTATIC STENT

FDA Premarket Approval P060010

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the spanner temporary prostatic stent. The device is intended for temporary use (up to 30 days) to maintain urine flow and allow voluntary urination in patients following minimally invasive treatment for benign prostatic hyperplasia (bph) and after initial post-treatment catheterization.

DeviceTHE SPANNER TEMPORARY PROSTATIC STENT
Generic NameStent, Urethral, Prostatic, Semi-permanent
ApplicantSRS MEDICAL
Date Received2006-03-14
Decision Date2006-12-14
Notice Date2006-12-26
PMAP060010
SupplementS
Product CodeNZC 
Docket Number06M-0529
Advisory CommitteeGastroenterology/Urology
Expedited ReviewNo
Combination Product No
Applicant Address SRS MEDICAL 76 Treble Cove Road, #3 north Billerica, MA 01862
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P060010Original Filing
S013 2020-06-22 Panel Track
S012
S011 2013-04-24 Normal 180 Day Track No User Fee
S010 2011-05-20 Real-time Process
S009 2011-05-20 30-day Notice
S008 2009-10-16 Real-time Process
S007 2009-04-28 Real-time Process
S006 2009-04-27 30-day Notice
S005 2009-04-21 Special (immediate Track)
S004 2009-03-16 30-day Notice
S003 2009-01-12 Real-time Process
S002 2008-03-20 30-day Notice
S001 2007-09-20 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.